Revised Safety Warnings Issued for MPA Following New Studies Linking Prolonged Use to Increased Risk of Meningioma.

alleging that Pfizer had knowledge of Depo-Provera’s potential to induce meningiomas but did not provide adequate warnings.

The lawsuit says that all U.S. labels of Depo-Provera were updated in July 2024, but meningioma risk was not included in the change “despite the overwhelming body of research.” The warnings ...

Some women who have used Depo-Provera for more than two years say they were not adequately warned about the health risks of taking it long term. However, warnings about osteoporosis risks and ...

In March, the British Medical Journal published a study finding women who used contraceptives like Depo-Provera for more than a year had a five-to-six-fold increased chance of developing a type of ...